Performance October 2026:
During October, the Pareturn Columbus Class I2 fund remained stable (+0.06 %), whilst the Stoxx 600 rose by 1.8 %. The fund has risen by 9.23 % since the start of the year. Over the last 12 months, the fund has recorded a gain of 12.79 %, and 61.8 % over the last three years. Columbus ranks in the top quartile of its category over 1-, 3- and 5-year periods, according to Morningstar data. Since its launch in June 2008, the fund has recorded a total return of 245.9 %, consistently outperforming the main European stock market indices.
Market environment:
October saw a reversal of the trend observed in September in US performance relative to Europe. The month began with the interest rate crisis still in the spotlight, and the yield on 10-year US government bonds briefly exceeded 5.3 per cent. Against this backdrop, the STOXX 600 rose by 1.9 per cent, whilst the S&P 500 fell by 0.9 per cent and the Nasdaq by 5.3 per cent. Looking beyond the surface, the rotation was markedly defensive: the healthcare sector recorded its best month since 1987 and the food, drink and tobacco sector its best ever, whilst semiconductors, banks and large industrial companies suffered a sharp fall.
Third-quarter results highlighted a widening gap between winners and losers. STOXX 600 earnings grew by around 28 per cent, but the energy sector is accounting for much of that growth, whilst the rate of earnings beating forecasts stands at just 42 per cent – the lowest since the fourth quarter of 2023. Revisions were also moderate, with the Energy and Technology sectors in positive territory, whilst Materials and Finance lagged behind.
Looking ahead to November, we remain optimistic about Europe, but are adopting an increasingly defensive stance as we approach the end of the year. Overall, we maintain a positive view on Europe, but we want that exposure to be increasingly focused on quality stocks, structural winners and idiosyncratic performers.
Performance of key holdings:
The best-performing stock of the month was REPLY (+15.5 % over the month). The Italian firm, which specialises in digital consultancy and IT services, continued its rally throughout October: Reply has established itself as a key player in the corporate implementation of generative AI, Agentic AI and Physical AI. It has solid long-term growth prospects. Our estimates point to 20 per cent growth in revenue and 23 per cent growth in profits over the next two years, supporting the share’s valuations.
As for Grifols (+14 %), after weathering a period of high volatility, the blood products multinational is consolidating its recovery in the market thanks to several factors. The company reassured the market by pointing out that it has already refinanced its most critical debt maturities due in 2027. This has given it greater financial flexibility and a lower leverage profile, which has once again attracted institutional funds. It also approved an interim dividend of €0.15 per share, sending a clear signal of financial stability. Finally, in Biopharma, strong growth in demand for immunoglobulins (particularly the subcutaneous treatment Xembify) more than offset the weakness in the albumin business in challenging markets such as China.
Download monthly factsheet [PDF]
Since May 2023, Spanish investors can access the Columbus strategy through the Spanish fund GVC Columbus European Equities FI. The Fund can be purchased through the AllFunds, Inversis and Fundsettle platforms. Columbus has a Master-Feeder structure. The Pareturn GVC Gaesco Columbus European Equity Fund in Luxembourg (master) and the GVC Columbus European Equities FI (feeder). The Luxembourg vehicle offers institutional and retail share classes denominated in euros and sterling.



















